Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says.

Study finds antibodies that target Epstein-Barr virus proteins can also attack proteins in the brain, increasing the likelihood of MS.

Researchers identified a monocyte/dendritic cell response to EBV reactivation in B cells as one of the earliest events in ...

EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, leading to symptoms such as ...

[46] Evidence supporting a role for EBV infection in MS pathogenesis come from ecological studies, observational epidemiological studies, co-occurring pathologies and experimental laboratory-based ...

Although EBV is treatable, it can trigger an array of diseases including autoimmune diseases. One major risk factor of multiple sclerosis (MS) includes EBV infection. MS is a chronic inflammatory ...

The risk of developing MS and other demyelinating diseases is 3 times greater in individuals diagnosed with EBV-positive IM.

Genes combined with immune response to Epstein-Barr virus increase MS risk. ScienceDaily . Retrieved March 24, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250310152912.htm ...

In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral ...

The etiologies of multiple sclerosis (MS) and systemic lupus erythematosus (SLE) are still unknown, but a growing body of evidence indicates that EBV could act as a trigger of both diseases.